U.S. CDMRP – Epilepsy Research Program | Research Funding
Event details
| Date | 19.05.2023 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Epilepsy Research Program (ERP) Awards. Several award programs are available:
All applications for ERP funding must specifically address at least one of the Focus Areas as directed by Congress and have direct relevance to military health. The FY23 ERP Focus Areas are listed at the end of this announcement.
Funding: Leveraging Research – max. $250K
Idea Development – $450K - $650K
Research Partnership – max. $1.2M
Duration: Leveraging Research – 3 years
Idea Development – 3 years
Research Partnership – 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Grants.gov Funding Opportunity Numbers:
Pre-Application Deadline: May 19, 2023 (5:00 p.m. Eastern time)
Full Application Deadline: June 28, 2023
Further information
FY23 ERP Focus Areas:
- The Leveraging Research Awards leverage ongoing or completed research studies for which post-traumatic epilepsy was not an original focus and to provide support to expand the research to develop such a focus and increase our understanding of PTE. The project may include basic, translational, and/or
clinical research studies. - The Idea Development Award supports novel, innovative research that has the potential to increase our understanding of post-traumatic epilepsy to improve quality of life.
- The Research Partnering Award aims to create an avenue to support new or existing collaborative research partnerships between/among investigators to address a research problem or question in a manner that would be unachievable through separate efforts. A minimum of two investigators must partner in
one overarching study.
All applications for ERP funding must specifically address at least one of the Focus Areas as directed by Congress and have direct relevance to military health. The FY23 ERP Focus Areas are listed at the end of this announcement.
Funding: Leveraging Research – max. $250K
Idea Development – $450K - $650K
Research Partnership – max. $1.2M
Duration: Leveraging Research – 3 years
Idea Development – 3 years
Research Partnership – 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Grants.gov Funding Opportunity Numbers:
- Leveraging Research Award – HT9425-23-ERP-LRA
- Idea Development Award – HT9425-23-ERP-IDA
- Research Partnership Award – HT9425-23-ERP-RPA
Pre-Application Deadline: May 19, 2023 (5:00 p.m. Eastern time)
Full Application Deadline: June 28, 2023
Further information
- To find the full program announcements, use the opportunity-specific links above to connect to Grants.gov
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY23 ERP Focus Areas:
- Markers and Mechanisms: Identifying biomarkers or mechanisms of PTE, which may include the following:
- Predictive biomarkers of epileptogenesis (acute and chronic)
- Research into the prevention of epilepsy and/or seizures
- Epidemiology: Epidemiological characterization of PTE following TBI, which may include the following:
- Understanding and improving the quality of life of individuals with PTE, their families, and/or their care partners
- Predictors of the development of epilepsy
- Outcomes, including latency to and prevention of epilepsy, comorbidities, and mortality
- Longitudinal Studies: Studies of the evolution of PTE, which may include the following:
- Understanding and improving the quality of life of individuals with PTE, their families, and/or their care partners
- Treatment and healthcare outcomes research, including quality of care
- Natural history of PTE and prognosis
- Comorbidities (e.g., depression, functional deficits, sleep disorders, major illness)
- Innovative Research: Tools intended to better inform or improve upon PTE research and care, which may include the following:
- Strategies that will improve seizure detection, characterization, visualization, or diagnosis
- Development of new models or better characterization of existing etiologically relevant models for PTE
Practical information
- General public
- Free